un Call IMI-2 sur la thématique vaccination & immuno-senescence (healthy aging) vient d’être lancé.
CoReVac has been established in 2011, on the proposal of Prof. Jean-François Delfraissy with IMMI (Institut de Microbiologie et Maladies Infectieuses) under the Aviesan umbrella. IMMI has now changed and is called I3M (Immunology, Inflammation, Infectiology and Microbiology)
I3M: This Institute brings together research teams working on microbiology and infectious diseases. Their task is to make significant breakthroughs by improving what we know of the microbial world and how it interacts with different environments.
Ten ITMOs are currently under the scope of Aviesan.
Professor Jean-Francois Delfraissy: He is professor of clinical immunology and internal medicine at the Paris-Sud Faculty of Medicine. He has been one of the pioneers in the fight against AIDS and started assisting patients infected by HIV as early as 1983 when working at the Antoine-Béclère hospital. Prof. Delfraissy continued his clinical career at the Bicêtre hospital where he has led the internal medicine department since 1996. The scientific career of JF Delfraissy began in 1975, the year he joined the Inserm (National Institute for Health and Medical Research), in Unit 131, “Immunology” laboratory. In 1995, he created the Inserm Unit “Viruses, neurones and immunity” which he co-leads. Professor JF Delfraissy has a seat on numerous national and international scientific boards; among these many positions, he was vice-president of the group of experts grouped together under Unaids in 2004, 2007 and 2009 to draw up recommendations and guidelines on the use of antiretroviral drugs in developing countries. Prof Delfraissy was also designed as of the group of experts commissioned by the French Ministry of Health from 1999 to 2005 to provide the recommendations for HIV/AIDS patients treatment and care.